Nephrocare Health Services Approves Grant of 38,236 Options Under ESOP 2026
Nephrocare Health Services Ltd · Others (Uncategorized) · 17 Nov 2026, 11:11 pm
Nephrocare Health Services Approves Grant of 38,236 Options Under ESOP 2026 Nephrocare Health Services Limited announced that its Nomination and Remuneration Committee approved the grant of 38,236 Employee Stock Options under the NephroPlus Employee Stock Option Scheme, 2026 via circular resolution on 17th Nov'26. Each option is convertible into one equity share of face value ₹2 at an exercise price of ₹513.60 per option. The options carry a minimum vesting period of one year from the grant date and can be exercised within a maximum period of five years from each respective vesting date.
Original exchange filing (PDF)
More announcements from Nephrocare Health Services Ltd
- Pursuant to Reg 30 of SEBI Listing Regulations, 2015, we hereby inform that the Company has approved allotment of 3,42,130 equity shares of Rs. 2/- each, pursuant to the exercise of stock .... · 17 Nov 2026
- Please find enclosed herewith Transcripts for the Investors Earnings call held on November 4, 2026. · 12 Nov 2026
- Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith. · 12 Nov 2026
- In Continuation to our letter dated October 21, 2026 please find enclosed link of the audio recording of the Investors'' Conference Call held on November 04, 2026 on the Unaudited Standalone .... · 04 Nov 2026
- Please find attached monitoring agency report for the quarter ended September 30, 2026. · 04 Nov 2026
- Please find investor presentation for quarter and half year ended September 30, 2026. · 03 Nov 2026
- Press release on Unaudited standalone and consolidated financial results for quarter and half year ended September 30, 2026. · 03 Nov 2026
- Outcome of the Board meeting held on November 3, 2026 for considering and approving the financial results for the period ended September 30, 2026. · 03 Nov 2026
